The expression of PLK1, a key regulator of cell cycle progression and a marker of cellular proliferation [18,19,20,21,22,23], was inversely correlated with the vector-prone increase in DAPK1 re-expression (Figure 3C), supporting an anti-proliferative role of DAPK1 in ovarian cancer. This evidence concerns the gene DAPK1 and ovarian cancer.